Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Ann Pharm Fr. 2012 May;70(3):120-32. doi: 10.1016/j.pharma.2012.03.002. Epub 2012 Apr 13.

    [Workplace testing of drugs of abuse and psychotropic drugs].

    [Article in French]

    Source

    Laboratoire de toxicologie et de pharmacocinétique, centre hospitalier universitaire, BP 577, Poitiers cedex, France.

    Abstract

    In France, workplace testing of drugs of abuse and psychotropic drugs is rarely performed; meanwhile it is a major public health problem. Furthermore, France is the European country that has been associated with the highest increase of the use of drugs of abuse, particularly cannabis. So workplace biological screening of drugs of abuse and of psychotropic drugs exposure is of major concern. New analytical techniques have been developed during the last years. The authors will consider analytical screening of drugs of abuse and particularly the comparison of analytical techniques applied to urine and saliva. The advantages and the disadvantages of these two matrices will be considered. Urinary and blood quantification will be reviewed, but also the interest of hair testing to explore chronic exposure. The research of psychotropic drugs in biological fluids is also a part of this paper. New analytical trends are promising and complete analysis of these substances will be soon routinely possible in blood using a single spot test.

    Copyright © 2012 Elsevier Masson SAS. All rights reserved.

    PMID:
    22655580
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Masson (France)

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk